Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides

Bioorg Med Chem. 2004 Nov 1;12(21):5595-601. doi: 10.1016/j.bmc.2004.08.003.

Abstract

We describe here the isolation of Reishi polysaccharides for the study of their effect on cytokine expression in mouse splenocytes. A fraction (F3) has been shown to activate the expression of IL-1, IL-6, IL-12, IFN-gamma, TNF-alpha, GM-CSF, G-CSF, and M-CSF, and from this three subfractions have been prepared where F3G1 activates IL-1, IL-12, TNF-alpha, and G-CSF, F3G2 activates all the cytokines as F3 does, and F3G3 activates only IL-1 and TNF-alpha. Together with previous studies, the mode of action on macrophages has been proposed where F3 binds to TLR4 receptor and activates extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 to induce IL-1 expression.

MeSH terms

  • Animals
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Cytokines / biosynthesis*
  • Dose-Response Relationship, Drug
  • Granulocyte Colony-Stimulating Factor / biosynthesis
  • Immunologic Factors / isolation & purification
  • Immunologic Factors / pharmacology*
  • Interleukin-1 / biosynthesis
  • Interleukin-12 / biosynthesis
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Polysaccharides / isolation & purification
  • Polysaccharides / pharmacology*
  • Reishi*
  • Spleen / drug effects
  • Spleen / metabolism
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Antineoplastic Agents
  • Cytokines
  • Immunologic Factors
  • Interleukin-1
  • Polysaccharides
  • Tumor Necrosis Factor-alpha
  • Granulocyte Colony-Stimulating Factor
  • Interleukin-12